Ireland
--:--IST
Latest
Clinical Trials in Spain / NCT05052736
Recruiting Not applicable

Non Invasive Neurostimulation Technology for the Treatment of Type I Complex Regional Pain Syndrome (CRPS I)

NCT05052736 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2022-03-28
Last updated
2025-08-28

Condition(s) studied

Type I Complex Regional Pain Syndrome

Investigational drug(s) / intervention(s)

Non-invasive Neuromodulation

Non-invasive Neuromodulation: The electrodes will be placed with the help of gloves and adapted socks for 1 hour, twice a week, until 20 intervention sessions are completed. In addition, depending on the session, an adhesive electrode will be placed at the level of C7. Characteristics of microcurrents: pulsed monophasic rectangular wave with a pulse of 1.3 s and pause of 300 ms, voltage 3 millivolt and intensity 0.5 μA.

Study summary

Complex Regional Pain Syndrome (CRPS) / Complex Regional Pain Syndrome (CRPS) is a chronic neurological disorder that affects the extremities and is characterized by disabling pain, swelling, vasomotor instability, sudomotor abnormality, and impaired motor function; the duration and clinical magnitude is greater than expected, being divided into three stages of progression over time: Stage I: acute (0-3 months); Stage II: dystrophic (3-9 months); Stage 3: atrophic (9-18 months).

The purpose of this study is to investigate the effect on complex pain syndrome using a conventional care protocol plus the application of non-invasive neuromodulation during compared to the effect of the same protocol plus placebo.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Meet the Budapest criteria for the clinical diagnosis of CRPS type I. * Age between 18 and 65. * Period between 0 and 6 months after the onset of the clinical picture. * Have signed the informed consent of their own free will. Exclusion Criteria: * Have a diagnosis of CRPS type II. * Present type I CRPS in more than one limb. * Patients who have suffered a recurrence of CRPS type I. * Pregnancy or plans for it during the study. * Previous sympathectomy in the affected limb.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Aníbal Báez Suárez Las Palmas de Gran Canaria Palmas, Las Recruiting

More University of Las Palmas de Gran Canaria trials in Spain

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05052736 on ClinicalTrials.gov ↗ ← All trials in Spain